(Q42216593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

pre-exposure prophylaxis against HIV

19 March 2020

main subject

1 reference

1 reference

A G A Jackson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

L J Else

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

D Egan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

D J Back

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Z Karolia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

L Ringner-Nackter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

C J Higgs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

B G Gazzard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

M Boffito

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

26 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

314-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Preexposure prophylaxis for HIV infection among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Coexistence of passive and carrier-mediated processes in drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.118

21 January 2018

Identifiers

DOI

10.1038/CLPT.2014.118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862215%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference